In vitro evaluation of the protective role of human antibodies to West Nile Virus (WNV) produced during natural WNV infection

Journal of Infectious Diseases

Volumn 198, Issue 9, 2008, Pages 1300-1308

  Rios, M ^a   Daniel, S ^a   Dayton, A I ^a   Wood, O ^a   Hewlett, I K ^a   Epstein, J S ^a   Caglioti, S ^c   Stramer, S L ^b,d  

^a Division of Viral Products   (United States)

^b AMERICAN RED CROSS   (United States)

^c Blood Systems Laboratories   (United States)

^d HFM 310 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS ANTIBODY; WEST NILE FLAVIVIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; HUMANS; MACROPHAGES; RNA, VIRAL; VERO CELLS; VIRAL LOAD; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS;

EID: 54249085339     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592277     Document Type: Article

References (25)

1. van der Meulen KM, Pensaert MB, Nauwynck HJ. West Nile virus in the vertebrate world. Arch Virol 2005; 150:637-57.
2. Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis - New York, 1999. MMWR Morb Mortal Wkly Rep 1999; 48:845-9.
3. Centers for Disease Control and Prevention. Statistics, surveillance and control for West Nile virus. Available at: http://www.cdc.gov/ncidod/dvbid/ westnile/index.htm. Accessed 4 March 2007.
4. O'Leary DR, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004;4:61-70.
5. Centers for Disease Control and Prevention. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:833-6.
6. Centers for Disease Control and Prevention Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877-8.
7. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1135-6.
8. Pealer LN, Marfin AA, Petersen, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236-45.
9. Busch MP, Tobler LH, Saldanha J, et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 2005; 45:492-9.
10. Stramer SL, Wagner AG, Paolillo JE, et al. West Nile Virus (WNV) tests identify units implicated in transfusion transmission [abstract S7-030B]. In: Transfusion, special abstract supplement, 56th Annual AABB Meeting (San Diego). 2003. Available at: http:// www3.interscience.wiley.com/cgi-bin/fulltext/ 118875080/PDFSTART. Accessed 25 August 2008.
11. Centers for Disease Control and Prevention. Update: West Nile Virus Screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:281-4.
12. Centers for Disease Control and Prevention. Transfusion-associated transmission of West Nile virus - Arizona, 2004. MMWR Morb Mortal Wkly Rep2004; 53:842-4.
13. Centers for Disease Control and Prevention. West Nile Virus Transmission Through Blood Transfusion - South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:76-9.
14. Stramer SL, Fang CT, Foster AG, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353:451-9.
15. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460-7.
16. Stramer SL, Foster GA, Paolillo JE, Wagner AG, Dodd RY, Brodsky JP. Dynamics of WNV infection and resolution among blood donors [abstract S14-030D]. In: Transfusion, special abstract supplement, 57th Annual AABB Meeting (Baltimore). 2004. Available at: http:// www3.interscience.wiley.com/cgi- bin/fulltext/118764403/PDFSTART. Accessed 25 August 2008.
17. Muerhoff AS, Dawson GJ, Dille B, et al. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid. Clin Diagn Lab Immunol 2004; 11:651-7.
18. Ratterree MS, Gutierrez RA, Travassos da Rosa APA, et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 2004; 189:669-76.
19. Prince HE, Lape'-Nixon M, Moore RJ, Hogrefe WR. Utility of the focus technologies West Nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol 2004; 42:12-5.
20. Prince HE, Hogrefe WR. Detection of West Nile virus (WNV)-specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States. Clin Diagn Lab Immunol 2003; 10:764-8.
21. Rios M, Zhang MJ, Srinivasan K, Daniel S, Hewlett I, Dayton A. Monocytes/ macrophages are a potential target in human infection with West Nile Virus (WNV) through blood transfusion. Transfusion 2006; 46:659-67.
22. Rios M, Sirnivasan K, Wood O, Daniel O, Tomioka K, Williams A, Hewlett I. West Nile Virus: correlation between infectivity and RNA copy number [abstract S9-030B]. In: Transfusion, special abstract supplement, 56th Annual AABB Meeting (San Diego). 2003. Available at: http://www3.interscience.wiley.com/cgi- bin/fulltext/118875080/PDFSTART. Accessed 25 August 2008.
23. Kuno G. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv Virus Res 2003; 61:3-65.
24. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, Roehrig JT. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9:544-9.
25. Wong SJ, Boyle RH, Demarest VL, et al. Immunoassay targeting non-structural protein 5 to differentiate West Nile virus infection from Dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 2003; 41:4217-23.